National Women's Health Week
May 06, 2014 12:04 ET | U.S. Food and Drug Administration
Silver Spring, MD, May 6, 2014 (GLOBE NEWSWIRE) -- May 11 -17, 2014 is National Women's Health Week. Throughout the week, the U.S. Food and Drug Administration (FDA) Office of Women's Health is...
On-X Life Technologies Inc. logo
On-X Life Technologies Submits for FDA/CE Approval of Reduced Anticoagulation Indication for On-X Aortic Heart Valve
October 22, 2012 08:01 ET | On-X Life Technologies Inc.
If approval is received, the On-X valve will become the first aortic valve that allows patients to be maintained at levels of anticoagulation below currently recommended professional society...
Hemispherx Biopharma and the FDA Reach Agreement on Filing Requirements for the Company's Complete Response in Support of Ampligen(R) New Drug Application for Chronic Fatigue Syndrome Treatment
July 11, 2012 08:00 ET | Hemispherx Biopharma, Inc.
PHILADELPHIA, July 11, 2012 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE:HEB) (the "Company" or "Hemispherx") recently met with representatives of the U.S. Food and Drug Administration (the...
MELA Sciences Announces FDA Advisory Panel Votes Positively for MelaFind(R) on Safety, Efficacy and Risk/Benefit Ratio
November 18, 2010 20:08 ET | MELA Sciences
COLLEGE PARK, MD--(Marketwire - November 18, 2010) - MELA Sciences, Inc. (NASDAQ: MELA) today announced that the General and Plastic Surgery Devices Panel appointed by the U.S. Food and Drug...
FDA Accepts Electro-Optical Sciences' MelaFind(R) Pre-Market Approval (PMA) Application for Review
August 04, 2009 07:37 ET | Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - August 4, 2009) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA) announced today that the U.S. Food and Drug Administration (FDA) formally accepted for filing the...
Electro-Optical Sciences Appoints Anne Egger to Board of Directors
June 10, 2009 07:30 ET | Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - June 10, 2009) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA) today announced that it has appointed Anne Egger to its Board of Directors. Ms. Egger brings more...
Electro-Optical Sciences Submits MelaFind(R) Pre-Market Approval Application to FDA
June 04, 2009 07:30 ET | Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - June 4, 2009) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA) today announced the submission to the United States Food and Drug Administration (FDA) of its...